Category
Standard
Type
Standard
Version
2
Access
Open
Status
Active
Created
2019
This is the current version.
This document sets out the minimum requirements for best-practice use of human papillomavirus (HPV) nucleic acid testing as the primary screening method for cervical screening, with reflect liquid-based cytology in cases of positive oncogenic HPV types. Testing of self-collected specimens of symptomatic women and in the post-treatment setting has also been considered.
Main sections:
- Personnel
- Facilities
- Specimens
- Equipment
- Quality assessment
- Reporting
- Program assurance measures
- Guidance on investigating HPV detection rates (informative)
- Achieving the program assurance measures and standards for PBC (informative)
- Information required to be provided to the National Cervical Screening Register (informative)
- Program assurance measures worksheets (normative)
Main sections:
- Personnel
- Facilities
- Specimens
- Equipment
- Quality assessment
- Reporting
- Program assurance measures
- Guidance on investigating HPV detection rates (informative)
- Achieving the program assurance measures and standards for PBC (informative)
- Information required to be provided to the National Cervical Screening Register (informative)
- Program assurance measures worksheets (normative)
Access Requirements for laboratories reporting tests for the National Cervical Screening Program
By accessing this content, you are leaving this website. The Agency takes no responsibility for the accuracy of content on the destination page.